Sellas Life Sciences Group Inc.
$11.32
▼ -8.27%
−$1.02
NASDAQ · Healthcare · Biotechnology
today's anomalySLS · NASDAQ · Healthcare · Biotechnology
$11.32
▼ -8.27% · −$1.02 today
strong
4 of 5 metrics · 80% coverage
Missing inputs are treated as neutral uncertainty; compared with sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $2.23B | - | - | 66 | |
| $10.45B | 17.9 | +23.5% | 78 | |
| $4.94B | 20.5 | - | 78 | |
| $27.61B | 30.6 | - | 77 | |
| $1.13T | 43.0 | - | 76 |
US stock research
Sellas Life Sciences Group Inc. trades on NASDAQ under the ticker SLS. This page brings the latest available price, returns, valuation, growth, analyst context, earnings dates, and relevant headlines into one research view. Use the timestamp to distinguish current market data from slower-moving fundamentals.
Market snapshot updated Jul 24, 2026, 8:10 PM UTC.
Stocksbrew for agents
It can retrieve the current call, target, drivers, risks, and freshness before answering.